Veradermics announces positive Phase 3 Study 302 topline results for VDPHL01 in male pattern hair loss by mariel | Apr 27, 2026 | Portfolio News
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus by mariel | Apr 27, 2026 | Portfolio News
Viridian Therapeutics reports positive Phase 3 REVEAL-1 results for elegrobart in active thyroid eye disease by mariel | Mar 30, 2026 | Portfolio News
Kestra Medical Technologies reports third quarter fiscal 2026 results; raises FY2026 revenue guidance to $93M, representing 55% growth vs. FY2025 by mariel | Mar 17, 2026 | Portfolio News
CytomX Therapeutics reports positive Phase 1 data for CX-2051 (Varseta-M) in colorectal cancer by mariel | Mar 16, 2026 | Portfolio News
